1. Home
  2. ITRG vs EOLS Comparison

ITRG vs EOLS Comparison

Compare ITRG & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRG
  • EOLS
  • Stock Information
  • Founded
  • ITRG 1997
  • EOLS 2012
  • Country
  • ITRG Canada
  • EOLS United States
  • Employees
  • ITRG N/A
  • EOLS N/A
  • Industry
  • ITRG Precious Metals
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ITRG Basic Materials
  • EOLS Health Care
  • Exchange
  • ITRG Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • ITRG 452.9M
  • EOLS 493.5M
  • IPO Year
  • ITRG N/A
  • EOLS 2018
  • Fundamental
  • Price
  • ITRG $2.79
  • EOLS $6.63
  • Analyst Decision
  • ITRG Strong Buy
  • EOLS Strong Buy
  • Analyst Count
  • ITRG 2
  • EOLS 5
  • Target Price
  • ITRG $3.25
  • EOLS $21.25
  • AVG Volume (30 Days)
  • ITRG 2.1M
  • EOLS 897.1K
  • Earning Date
  • ITRG 11-12-2025
  • EOLS 11-05-2025
  • Dividend Yield
  • ITRG N/A
  • EOLS N/A
  • EPS Growth
  • ITRG N/A
  • EOLS N/A
  • EPS
  • ITRG 0.09
  • EOLS N/A
  • Revenue
  • ITRG $148,447,000.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • ITRG $871.24
  • EOLS $14.01
  • Revenue Next Year
  • ITRG N/A
  • EOLS $29.46
  • P/E Ratio
  • ITRG $30.12
  • EOLS N/A
  • Revenue Growth
  • ITRG N/A
  • EOLS 17.15
  • 52 Week Low
  • ITRG $0.79
  • EOLS $5.71
  • 52 Week High
  • ITRG $2.86
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • ITRG 82.35
  • EOLS 34.55
  • Support Level
  • ITRG $2.54
  • EOLS $6.60
  • Resistance Level
  • ITRG $2.86
  • EOLS $7.58
  • Average True Range (ATR)
  • ITRG 0.12
  • EOLS 0.30
  • MACD
  • ITRG 0.03
  • EOLS -0.03
  • Stochastic Oscillator
  • ITRG 91.36
  • EOLS 2.62

About ITRG Integra Resources Corp.

Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: